Fact CheckerSign in

NCT06652464Completed

Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis

The Relationship Between Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis

Source: ClinicalTrials.gov · Last updated 7 Mar 2025

Brief summary (registry, in English)

Specialized pro-resolving mediators (SPMs), which are typically thought to be formed via consecutive steps of oxidation of polyenoic fatty acids, have been shown to suppress inflammation and promote timely resolution of inflammation. They are mainly divided into four categories: lipoxins, resolvins, protectins, and maresins. The study will compare Maresin-1 and Resolvin-D1 levels in ulcerative colitis patients with those in the control group.

Status (registry)
Completed
Study type
Observational
Enrollment
90 (actual)
First submitted
15 Oct 2024
Start date
1 Aug 2024
Primary completion date
1 Nov 2024
Lead sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
NCT number
NCT06652464

What you commit to

  • Study type: Observational
  • Participants enrolled: 90
  • From 1 Aug 2024 to the primary completion date, 1 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Active malignancy
  • Chronic kidney disease
  • Diabetes mellitus
  • Collagen tissue disease
  • History of colectomy
  • Acute infection
  • Within the past week, history of omega-3 dietary supplementation, non-steroidal anti-inflammatory drug use, or fish consumption.

Other

  • Pregnancy / lactation period

Who the study is looking for

  • Patients with ulcerative colitis in active and remission phases, and a control group without acute or chronic inflammatory disease.

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Abdurrahman Yurtaslan Oncology and Training Research Hospital
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.